Clinuvel Pharmaceuticals LimitedASX: CUV

Appendix 4G

· Issued by Clinuvel Pharmaceuticals Limited via ASX

Filed with ASX ·

On 6ix: 6ix.com/news/appendix-4g-115

Watch Clinuvel Pharmaceuticals' latest callClinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call · Replay · Aug 27Read the transcript of Clinuvel Pharmaceuticals (ASX:CUV) Q4 2026 Earnings Call

Rules 4.7.3 and 4.10.3 ASX Listing Rules Appendix 4G (current at 17/7/2020) Page 1 Appendix 4G Key to Disclosures Corporate Governance Council Principles and Recommendations Name of entity CLINUVEL PHARMACEUTICALS LIMITED ABN/ARBN Financial year ended: 089 644 119 30 June...

View Attachment

6ix hasn’t read this filing yet.

Clinuvel Pharmaceuticals Limited on 6ix

In the deck

Earlier from Clinuvel Pharmaceuticals

Later from Clinuvel Pharmaceuticals

All Clinuvel Pharmaceuticals news releases